Inflexion's Pharma Services dinner

The Inflexion Healthcare team was delighted to host a Pharma Services dinner in London this week, bringing together a select group of senior leaders from the sector to discuss current challenges and opportunities.

The discussion was led by the accomplished advisor and board director, Charles Woler. Charles chairs Inflexion's portfolio company Upperton Pharma Solutions and serves as a Board Director for several other pharma-related businesses, including Sygnature Discovery. His impressive career includes roles as CEO of Roche France, Executive Chair for Europe at SmithKline Beecham PLC, and CEO of Cadus Pharmaceutical in the US. Additionally, Charles founded the French biotech company Neuro3d, which he later sold, co-founded the Swiss biopharmaceutical firm Inflamalps, and served as CEO of Biomnis, one of the largest independent laboratories in Europe.